PCRX
Pacira BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
PCRX vs peer average
72/100
PCRX vs. peer average (B vs. C)
Grade spread
B 4 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Same-sector and similar-market-cap candidate, but no direct commercial or clinical operating match was established; peer signal is weak.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PCRX
Pacira Biosciences
ABUS
Arbutus Biopharma
Grade
B
B
Momentum
99
25
Value
65
55
Sentiment
47
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABUS
PCRX / ABUS
Grade Position
Above peers
PCRX vs. peer average (B vs. C)
72/100
Momentum
99
PCRXValue
65
PCRXSentiment
47
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PCRX
ABUS is the first peer returned for this comparison set.